The Center for Biopharma Analysis (CBA) at Venture Center proudly offers world-class, GLP-compliant bioassay services tailored to accelerate your biopharmaceutical innovations. Whether you're validating monoclonal antibodies or optimizing potency, our expert services ensure precision and reliability.

Our Premier Services:

1. ADCC Assay Services

Explore Immune Activation Like Never Before!

Purpose: Evaluate Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) to assess effector function of the Therapeutic mAb.

Why Choose Us?

• Ready-to-use validated assays with cutting-edge, genetically engineered effector cells.
• High-throughput options for faster results at scale (96- and 384-well formats).
• Custom method development to meet your specific needs.
• Data analysis using PLA software, one of the very well accepted software across all regulatory agencies for assay and sample suitability and relative potency determination.

 

What You Get: A comprehensive report with reportable %relative potency values, dose response curve, raw data, and statistical insights.

2. CDC Assay Services

Measuring the Impact of Complement-Mediated Cell Lysis

Purpose: Analyze Complement-Dependent Cytotoxicity (CDC), a critical mechanism for therapeutic antibodies.

Why Choose Us?

• Proven, reliable assays leveraging rabbit complement.
• Precision-driven customization for unique project requirements.
• Detect cell lysis using metabolic activity indicators for superior accuracy.
• Data analysis using PLA software, one of the very well accepted software across all regulatory agencies for assay and sample suitability and relative potency determination.

 

What You Get: Detailed report with reportable %relative potency values to support regulatory submissions and publications, raw data and dose response curve.

 

3. C1q Binding Assay Services

Unlock the Power of Antibody Binding!

Purpose: Measure antibody-C1q binding, the gateway to complement system activation.

Why Choose Us?

• Advanced ELISA-based assays in high-throughput formats.
• Tailored solutions for robust method qualification and validation.
• Ideal for evaluating the therapeutic efficacy of CDC-reliant monoclonal antibodies.

 

What You Get: A polished report with % relative binding activity of the antibody under study, dose response curve, raw data and statistical insights.

Why CBA is Your Trusted Partner

• GLP-Compliant Excellence: Adhering to ICH guidelines for rigorous quality.
• Custom Solutions: Tailored method development, validation, and reporting.
• Sample analysis for relative potency determinations, stability sample studies. Biosimilar and RMP/RP comparative studies, any protocol driven studies with complete documentation, analyses etc.
• Flexible Pricing: Discounts for startups, academic institutions, and bulk samples.

 

Getting Started is Easy

• Book a Consultation: Connect with our expert Business Development Team to explore options.
• Submit Your Request: Complete the application form and receive a customized invoice.
• Watch Innovation Happen: Let our experts handle the rest while you focus on breakthroughs!

 

Get started today! Contact us for a free consultation or book a service https://tinyurl.com/ffdz2nam

For enquiries, contact:

Rutuja Patil

Email: rutuja.patil@venturecenter.co.in

Phone: +91 8956677542

The Center for Biopharma Analysis at Venture Center has recently announced cutting edge bioassay services which could be of immense benefit to biotech startups/ companies in the ecosystem.